SEC CIK 1836013
Bamford Lynn M
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CWview stock → | 45,651 | 2026-07-06 |
Position History — CW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-06 | Grant / award | 17 | $634.88 | 45,651 |
| 2026-06-12 | Open-market sale | 2,500 | $758.20 | 45,634 |
| 2026-06-09 | Open-market sale | 2,500 | $721.72 | 48,134 |
| 2026-03-17 | Open-market sale | 3,225 | $676.70 | 50,634 |
| 2026-03-16 | Option exercise (derivative) | 7,667 | $0.00 | 14,614 |
| 2026-03-16 | Option exercise | 7,667 | $0.00 | 53,859 |
| 2026-03-09 | Grant / award (derivative) | 2,735 | $0.00 | 22,281 |
| 2026-02-04 | Open-market sale | 9,327 | $626.45 | 46,192 |
| 2026-02-03 | Grant / award | 20,268 | $674.32 | 55,519 |
| 2026-01-05 | Grant / award | 22 | $472.17 | 35,251 |
| 2025-12-11 | Gift | 184 | $0.00 | 35,229 |
| 2025-11-14 | Open-market sale | 3,750 | $549.07 | 35,413 |
| 2025-11-11 | Open-market sale | 3,750 | $577.79 | 39,163 |
| 2025-07-02 | Grant / award | 26 | $414.23 | 42,913 |
| 2025-03-18 | Open-market sale | 3,131 | $325.41 | 42,887 |
| 2025-03-17 | Option exercise (derivative) | 7,113 | $0.00 | 19,508 |
| 2025-03-17 | Option exercise | 7,113 | $0.00 | 46,018 |
| 2025-03-10 | Grant / award (derivative) | 5,630 | $0.00 | 26,621 |
| 2025-02-05 | Open-market sale | 8,289 | $346.87 | 38,905 |
| 2025-02-04 | Grant / award | 18,746 | $344.57 | 47,194 |
| 2025-01-06 | Open-market buy | 34 | $304.12 | 28,448 |
| 2024-12-16 | Gift | 274 | $0.00 | 28,414 |
| 2024-12-11 | Open-market sale | 7,129 | $368.80 | 28,688 |
| 2024-07-03 | Open-market buy | 44 | $232.62 | 35,817 |
| 2024-03-19 | Conversion (derivative) | 5,920 | $244.73 | 20,932 |
| 2024-03-19 | Open-market sale | 2,620 | $243.60 | 35,773 |
| 2024-03-19 | Grant / award | 5,920 | $0.00 | 38,393 |
| 2024-03-14 | Grant / award (derivative) | 6,209 | $240.97 | 26,852 |
| 2024-02-08 | Open-market sale | 6,962 | $224.94 | 32,473 |
| 2024-02-08 | Grant / award | 15,560 | $226.88 | 39,436 |
| 2024-02-06 | Option exercise (derivative) | 8,609 | $0.00 | 20,643 |
| 2024-02-06 | Option exercise | 8,609 | $225.95 | 27,721 |
| 2024-02-06 | Open-market sale | 3,845 | $225.56 | 23,876 |
| 2024-01-04 | Open-market buy | 52 | $189.32 | 19,112 |
| 2023-07-10 | Open-market buy | 62 | $155.43 | 19,060 |
| 2023-03-21 | Conversion (derivative) | 2,979 | $0.00 | 29,169 |
| 2023-03-21 | Open-market sale | 1,337 | $171.10 | 18,998 |
| 2023-03-21 | Conversion | 2,979 | $0.00 | 20,335 |
| 2023-03-17 | Grant / award (derivative) | 7,600 | $0.00 | 32,148 |
| 2023-02-15 | Grant / award | 4,842 | $170.30 | 19,579 |
| 2023-02-15 | Open-market sale | 2,223 | $169.42 | 17,356 |
| 2023-01-04 | Grant / award | 70 | $141.46 | 14,737 |
| 2022-07-07 | Grant / award | 74 | $111.35 | 14,667 |
| 2022-03-17 | Grant / award (derivative) | 7,030 | $0.00 | 24,470 |
| 2022-03-15 | Conversion (derivative) | 2,011 | $0.00 | 17,440 |
| 2022-03-15 | Conversion | 2,011 | $144.85 | 15,551 |
| 2022-03-15 | Open-market sale | 958 | $144.78 | 14,593 |
| 2022-02-16 | Grant / award | 2,189 | $138.03 | 14,599 |
| 2022-02-16 | Open-market sale | 1,059 | $137.26 | 13,540 |
| 2022-01-06 | Grant / award | 77 | $117.82 | 12,410 |
| 2021-07-07 | Option exercise | 76 | $100.43 | 12,333 |
| 2021-03-18 | Grant / award (derivative) | 5,835 | $0.00 | 19,391 |
| 2021-03-16 | Open-market sale | 750 | $120.47 | 12,257 |
| 2021-03-15 | Conversion (derivative) | 1,543 | $0.00 | 13,556 |
| 2021-03-15 | Conversion | 1,543 | $123.49 | 13,007 |
| 2021-02-05 | Open-market sale | 967 | $113.42 | 11,464 |
| 2021-02-03 | Grant / award | 2,023 | $110.34 | 12,431 |
| 2021-01-04 | — | — | — | 10,408 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.